Jamp Pharma Group

Jamp Pharma Group company information, Employees & Contact Information

JAMP Pharma, including its affiliates, is a privately owned Canadian company whose head office is located in Boucherville, 20 minutes from Montreal. Having experienced phenomenal growth, we are among the leading players in the generic pharmaceutical industry in Canada, with close to 345 molecules in our portfolio. JAMP Pharma also owns the natural health products Wampole, Laboratoire Suisse, Cosmétique Import and prescription products from Orimed Pharma. With the primary goal of providing quality health products, the departments of sales, research and development, logistics, customer service, quality assurance, regulatory affairs, market access, marketing, business development and export are committed to provide excellent customer service on a daily basis. Our employees stand out for their willingness to go the extra mile for our customers. We foster a work environment where innovation, teamwork and recognition are present. Our values are based on performance, passion, open communication, respect, integrity and customer satisfaction. With a turnover that has been growing steadily for more than 10 years, encouraging the promotion of our employees internally and the growth of our workforce, JAMP Pharma is regularly looking for talented candidates who want to thrive in a stimulating work environment. As part of JAMP Pharma, you will be able to: • Achieve your professional goals while having a significant impact on the success of the company. • Perform in a fast, agile, entrepreneurial and friendly environment. • Work with talented and multicultural professionals in order to achieve common goals. • Be part of a stable, successful and ambitious company at the forefront of innovation • Take advantage of our new, bright and welcoming offices. • Get involved socially with employees as well as the community. WANT TO MAKE HISTORY WITH US?

Company Details

Employees
624
Founded
-
Address
1310 Nobel, Boucherville,québec J4b 5h3,canada
Phone
450-449-1236
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Boucherville, Québec
Looking for a particular Jamp Pharma Group employee's phone or email?

Jamp Pharma Group Questions

News

Kashiv BioSciences and JAMP Pharma Corporation Announce the Launch of PEXEGRA® and FILRA® Biosimilars in Canada - Yahoo Finance

Kashiv BioSciences and JAMP Pharma Corporation Announce the Launch of PEXEGRA® and FILRA® Biosimilars in Canada Yahoo Finance

JAMP Pharma Group launches PrPexegra® (pegfilgrastim) and PrFilra® (filgrastim), two new biosimilar therapeutic options in oncology - PR Newswire Canada

JAMP Pharma Group launches PrPexegra® (pegfilgrastim) and PrFilra® (filgrastim), two new biosimilar therapeutic options in oncology PR Newswire Canada

Public advisory - JAMP-Pregabalin 50 mg: One lot recalled as some bottles may contain 150 mg capsules - Yahoo Finance

Public advisory - JAMP-Pregabalin 50 mg: One lot recalled as some bottles may contain 150 mg capsules Yahoo Finance

National recall issued for common pain medication over dosage issue - CTV News

National recall issued for common pain medication over dosage issue CTV News

Orimed Pharma announces the availability in Canada of PrSolufy™, a new liquid solution of aripiprazole - PR Newswire Canada

Orimed Pharma announces the availability in Canada of PrSolufy™, a new liquid solution of aripiprazole PR Newswire Canada

Audrina 28 birth control pill stickers misprinted in some lots, Health Canada says - CBC

Audrina 28 birth control pill stickers misprinted in some lots, Health Canada says CBC

Fonds de solidarité FTQ acquires 31 pct stake in Jamp Pharma - pehub.com

Fonds de solidarité FTQ acquires 31 pct stake in Jamp Pharma pehub.com

JAMP Pharma Group Acquires A Mfg. Facility In Lévis, Que. - Canadian Manufacturing

JAMP Pharma Group Acquires A Mfg. Facility In Lévis, Que. Canadian Manufacturing

Public advisory - Three lots of JAMP Valproic Acid Oral Solution recalled - PR Newswire Canada

Public advisory - Three lots of JAMP Valproic Acid Oral Solution recalled PR Newswire Canada

JAMP Pharma Corporation issues a voluntary recall of one (1) lot of its Atorvastatin tablets, 40 mg, 500-format for lot MHC1403A (Health Canada's Public advisory RA-64446) - PR Newswire Canada

JAMP Pharma Corporation issues a voluntary recall of one (1) lot of its Atorvastatin tablets, 40 mg, 500-format for lot MHC1403A (Health Canada's Public advisory RA-64446) PR Newswire Canada

Public advisory - Audrina 28 birth control pills: Day-of-the-week stickers in some lots have a misprint that could lead to confusion around dosing - PR Newswire Canada

Public advisory - Audrina 28 birth control pills: Day-of-the-week stickers in some lots have a misprint that could lead to confusion around dosing PR Newswire Canada

JAMP Pharma Group announces the commercial launch and product availability for PrJamteki™, the first biosimilar of Stelara® (ustekinumab) in Canada - PR Newswire Canada

JAMP Pharma Group announces the commercial launch and product availability for PrJamteki™, the first biosimilar of Stelara® (ustekinumab) in Canada PR Newswire Canada

Public advisory - Recall of one lot of JAMP Guanfacine XR 4 mg tablets due to contamination with foreign matter - PR Newswire Canada

Public advisory - Recall of one lot of JAMP Guanfacine XR 4 mg tablets due to contamination with foreign matter PR Newswire Canada

BIOJAMP ™: A Range of Biosimilars for a Seamless Approach - PR Newswire Canada

BIOJAMP ™: A Range of Biosimilars for a Seamless Approach PR Newswire Canada

Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care - PR Newswire Canada

Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care PR Newswire Canada

JAMP Pharma Group launches a new generic drug for the treatment of attention deficit hyperactivity disorder (ADHD) - PR Newswire Canada

JAMP Pharma Group launches a new generic drug for the treatment of attention deficit hyperactivity disorder (ADHD) PR Newswire Canada

JAMP Pharma Group Acquires a Pharmaceutical Manufacturing Facility in Lévis, Quebec - PR Newswire Canada

JAMP Pharma Group Acquires a Pharmaceutical Manufacturing Facility in Lévis, Quebec PR Newswire Canada

JAMP Pharma Group signs a landmark partnership agreement for the commercialization of five biosimilar medicines in Canada - PR Newswire Canada

JAMP Pharma Group signs a landmark partnership agreement for the commercialization of five biosimilar medicines in Canada PR Newswire Canada

JAMP Pharma Group improves drug access and affordability for multiple sclerosis patients in Canada - PR Newswire Canada

JAMP Pharma Group improves drug access and affordability for multiple sclerosis patients in Canada PR Newswire Canada

Jamp Pharma commissions its first facility outside Canada in Hyderabad - The New Indian Express

Jamp Pharma commissions its first facility outside Canada in Hyderabad The New Indian Express

UP Court restrains Jamp Pharma from using Jubilant Generics' confidential data| SCC Times - SCC Online

UP Court restrains Jamp Pharma from using Jubilant Generics' confidential data| SCC Times SCC Online

Canadian Jamp Pharma commissions new facility in Hyd, to invest ₹250 cr in Hyderabad facility - BusinessLine

Canadian Jamp Pharma commissions new facility in Hyd, to invest ₹250 cr in Hyderabad facility BusinessLine

Top Jamp Pharma Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant